
A retrospective case series examined ophthalmic complications in patients using semaglutide or tirzepatide. Nine patients (mean age 57.4 years) were included, reporting conditions such as nonarteritic ischemic anterior optic neuropathy, papillitis, and maculopathy. The complications varied, with atypical features like sequential optic neuropathy and progressive vision loss. While a causal link between these drugs and the complications couldn't be confirmed, the rapid correction of hyperglycemia may be a contributing factor.
Like
Save
Share